From Beth Lewin Dean, CEO <[email protected]>
Subject ReSearching to CURE Epilepsy: Fall 2022
Date November 18, 2022 2:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
We have made an impact on the epilepsy community together. See how.

[link removed]
Dear Friend of CURE Epilepsy,
As the end of the year approaches, I want to thank you, our amazing community, for all of your support throughout the year. We have continued to fulfill our mission of funding patient-focused research to find a cure for epilepsy, and I am excited to share our latest ReSearching to CURE Epilepsy ([link removed]) report with you. This report includes recent inspiring research, incredible personal stories from the epilepsy community, and a look at some of the new programs CURE Epilepsy has introduced to advance our mission of finding a cure.
Read the Report ([link removed])
Highlights from this latest issue of ReSearching to CURE Epilepsy ([link removed]) include:

* Our new Rare Epilepsy Partnership Award, a collaborative effort aimed at stimulating and accelerating research to help find cures for rare genetic epilepsies

* A research breakthrough on post-traumatic epilepsy (PTE) that shows promise in understanding more about the changes in brain activity that occur during the period between brain injury and PTE onset

* A new research project whose goal is to help improve the diagnosis and treatment of Jeavons syndrome, an underreported type of epilepsy that can be difficult to diagnose and treat

* A look at some of the incredible events (both in-person and virtual) of 2022


We are unrelenting each and every day in our search to find a cure. And with the support from members of our community like yourself, we will not stop until we achieve a world without epilepsy.

Through research there is hope.

With sincerest gratitude,


Beth Lewin Dean, CEO
CURE Epilepsy
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]

============================================================
Copyright © 2022 CURE Epilepsy, All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.

Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
CURE Epilepsy . 420 Wabash Ave, Ste 650 . Chicago, IL 60611 . USA
Screenshot of the email generated on import

Message Analysis